Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia

Recruiting N/A Interventional Study
Schizophrenia and Related Disorders
Ready to participate?

Review the details below, then apply to join this clinical trial.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to provide an effective repetitive transcranial magnetic stimulation (rTMS) treatment for depressive symptoms in patients with schizophrenia. Schizophrenia patients with depressive symptoms will be exposed to rTMS to improve their symptoms.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Male and female ages between ages 18-60 years. * Ability to give written informed consent (age 18 or above). * Diagnosed with schizophrenia-spectrum disorder and Evaluation to Sign Consent (ESC) above 10. * Score of Calgary depression scale for schizophrenia (CDSS) ≥ 3. Exclu…
Contacts

Alina Siatka

713-486-2740

Alina.Siatka@uth.tmc.edu

CONTACT

Xiaoming Du, PhD

443-882-9717

Xiaoming.Du@uth.tmc.edu

CONTACT